PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Powiadomienia systemowe
  • Sesja wygasła!
  • Sesja wygasła!
  • Sesja wygasła!
  • Sesja wygasła!
  • Sesja wygasła!
Tytuł artykułu

Radiochemia w medycynie nuklearnej : radiofarmaceutyki

Identyfikatory
Warianty tytułu
EN
Radiochemistry in nuclear medicine : radiopharmaceuticals
Języki publikacji
PL
Abstrakty
EN
Radionuclides and radiopharmaceuticals play the key role in nuclear medicine, both in diagnostics and therapy. Incorporation of radionuclides into biomolecules, and syntheses of radiolabelled compounds of light biological selectivity are a task for radiochemists working in the multidisciplinary field of radiopharmaceutical chemistry. The most commonly used radionuclide, 99mTc, owes this popularity to its both nearly ideal nuclear properties in respect to medical imaging, and availability from inexpensive radionuclide generators. Also numerous other radionuclides are widely used for medical imaging and therapy. Labelling of biomolecules with radioiodine and various positron emitters is getting increasingly important. This review describes some chemical and radiochemical problems we meet while synthesizing and using 99mTc-radiopharmaceuticals and radioiodine-labelled biomolecules. Also represented are the recent developments in the design and use of the second generation radiopharmaceuticals based on bifunctional radiochelates. Several principal routes of fast chemical synthesis concerning incorporation of short-lived positron emitters into biomolecules are outlined as well. The search for chemical structures of high biological selectivity, witch would be activated by slow neutrons, is related to the method of Neutron Capture Therapy, an interesting option in nuclear medicine.
Rocznik
Strony
661--699
Opis fizyczny
Bibliogr. 77 poz., tab., wykr.
Twórcy
  • Wydział Chemii Uniwersytetu Warszawskiego, ul. Żwirki i Wigury 101, 02-089 Warszawa
  • Wydział Chemii Uniwersytetu Warszawskiego, ul. Żwirki i Wigury 101, 02-089 Warszawa
Bibliografia
  • [1] H. N. Wagner, Z. Szabo, J. W. Buchanan Principles of Nuclear Medicine, W. B. Saunders Comp., Philadelphia, Pennsylvania 1995.
  • [2] J. R. Dilworth, S. J. Parott, Chem. Soc. Rev., 1998, 27, 43.
  • [3] F. Rosch, A. F. Novgorodov, S. M. Qaim, Radiochim. Acta, 1994, 64, 113.
  • [4] M. Nicolini, G. Bandoli, F. Refosco, F. Tisato, A. Moresco, A. Duatti, [w:] Technetium and Rhenium in Chemistry and Nuclear Medicine, Raven Press, New York 1989, s. 40.
  • [5] U. Mazzi, Polyhedron, 1989, 8, 1683.
  • [6] A. D. Nunn, M. D. Loberg, R. A. Conly, J. Nucl. Med., 1983, 24, 423.
  • [7] H. F. Kung, Y.-Z. Guo, C.-C. Yu, J. Billings, V. Subramanyam, J. C. Calabrese, J. Mei Chem, 1989, 32, 433.
  • [8] E. H. Cheesman, M. A. Blanchette, M. V. Ganey, L. J. Maheu, S. J. Miller, A. D. Watson, J. Nucl. Med. 1988, 29, 788.
  • [9] M. J. Welch, J. B. Downer, J. A. Katzenellenbogen, [w:] Current Directions in Radio-pharmaceutical Research and Development, S. J. Mather (red.) Kluwer Acad. Press, Nether¬lands 1996, 137.
  • [10] H. F. Kung, H. J. Kim, M. P. Kung, S. K. Meegda, K. Plossl, H. K. Lee, Eur. J. Nucl. Med., 1996, 23, 1527.
  • [11] D. Pressman, G. Keighly, J. Immunol., 1948, 59, 141.
  • [12] M. W. Brechbiel, O. A. Gansow, R. W. Atcher, J. Schlom, C. J. Esteban, D. E. Simpson, D. Colcher, Inorg. Chem., 1986, 25, 2772.
  • [13] Y. Arano, A. Yokoyama, Y. Magata, H. Saji, K. Horiuchi, K. Torizuka, Int. J. Nucl. Med. Biol., 1985, 12, 425.
  • [14] A. R. Fritzberg, Nuklearmedizin, 1987, 26, 7.
  • [15] M. K. Moi, C. F. Meares, M. J. McCall, W. C. Cole, S. J. DeNardo, Anal. Biochem, 1985, 148, 249.
  • [16] M. W. Brechbiel, O. A. Gansow, Bioconj. Chem., 1991, 2, 187.
  • [17] D. J. Hnatowich, W. W. Layne, R. L. Childs, Science, 1982, 220, 613.
  • [18] D. J. Hnatowich, G. Mardirossan, M. Ruscowski, M. Fargarasi, F. Firzi, P. Win- nard, J. Nucl. Med, 1993, 34, 172.
  • [19] J. D. Rodwell, V. L. Alvarez, C. Lee, A. D. Lopes, J. W. F. Goers, H. A. King, H. J. Powsner, T. J. McKearn. Proc. Natl. Acad. Sei. USA, 1986, 83, 2632.
  • [20] R. E. Weiner, M. L. Thakur, Radiochimica Acta, 1995, 70, 273.
  • [21] R. E. Weiner, Nucl. Med. Biol., 1996, 23, 745.
  • [22] E. K. J. Pauwels, V. R. McCready, J. H. M. Stoot, D. F. P. van Deurzen, Eur. J. Nucl. Med., 1998, 25, 277.
  • [23] E. P. Krenning, D. J. Kwekkeboom, W. H. Baker, ibid., 1993, 20, 716.
  • [24] M. L. Thakur, J. P. Lavender, R. N. Arnot, J. Nucl. Med., 1977, 18, 1014.
  • [25] A. J. Lomant, G. Fairbanks, J. Mol. Biot, 1976, 104, 243.
  • [26] P. M. Abdella, P. K. Smith, G. P. Royer, Biochem. Biophys.Res. Commun, 1979,87,734.
  • [27] S. M. Quadri, Ch. H. Paik, R. C. Reba, W.-P. Hong, [w:] Cancer Imaging with Radio-labeled Antibodies, D. M. Goldenberg (red.), Kluwer Acad. Publ. Boston, Dordrecht, London 1990, 201.
  • [28] H. L. Atkins, T. F. Budinger, E. Lebowitz, J. Nucl. Med., 1977, 18, 133.
  • [29] A H. Elgazzar, M. Fernandez-Ulloa, E. B. Silberstein, Nucl. Med. Commun., 1993, 14, 96.
  • [30] B. J. Hoffman, U. Scheffel, J. R. Lever, M. D. Karpa, P. R. Hartig, J. Neurochem., 1987, 48, 115.
  • [31] H. F. Kung, J. J. Billings, Y.-Z. Guo, M. Blau, R. Ackerhalt, Nucl. Med. Biol., 1988,15, 187.
  • [32] N. P. G. L. Verhoeff, Eur. J. Nud. Med. 1991, 18, 482.
  • [33] R. M. Baldwin, Int. J. Appl. Rad. Isot, 1986, 37, 817.
  • [34] H. F. Kung, K. M. Tromposch, M. Blau, J. Nucl. Med., 1983, 24, 66.
  • [35] T. J. Mangner, J. Wu, D. M. Wieland, J. Org. Chem., 1982, 47, 1484.
  • [36] L. Lawkins, A. Elliot, R. Shields, Eur. J. Nud. Med., 1982, 7, 58.
  • [37] K. Scheidhauer, S. Muller, K. Smolarz, P. Brautigam, B. Briele, Nuklearmedizin, 1991, 30, 84.
  • [38] S. D. Sharma, F. Toth, V. J. Hruby, J. Org. Chem, 1991, 56, 4981.
  • [39] D. S. Wilbur, Bioconj. Chem., 1992, 3, 433.
  • [40] A. E. Bolton, W. M. Hunter, Biochem. J, 1973, 133, 529.
  • [41] G. Kloster, P. Laufer, G. Stocklin, J. Labell. Comp. Radiopharm, 1983, 20, 391.
  • [42] G. Stocklin, S. M. Qaim, F. Rosch, Radiochimica Acta, 1995, 70, 252.
  • [43] G. W. Kabalka, Acc. Chem. Res, 1984, 17, 215.
  • [44] H. Herzog, R. J. Seitz, L. Tellmann, G. Schlang, A. Kleinschmidt, B. Nebeling, G. Stocklin, H. W. Muller-Gartner, Eur. J. Nucl. Med, 1994, 21, 138.
  • [45] J. M. Link, J. C. Clark, P. Larsen, K. A. Krohn, J. Labell. Comp. Radiopharm, 19^5, 37, 76.
  • [46] E. S. Garnett, G. Firnau, C. Nahmias, Nature, 1983, 305, 137.
  • [47] K. Hamach, H. H. Coenen, G. Stocklin, J. Nucl. Med., 1986, 27, 235.
  • [48] F. F. Knapp, Jr. S. Mirzadeh, Eur. J. Nucl. Med., 1994, 21, 1151.
  • [49] V. J. Lewington, ibid., 1992, 22, 3.
  • [50] R. A. Holmes, Sem. Oncol., 1993, 20 (Supp. 2), 22.
  • [51] W. A. Volkert, E. A. Deutsch, [w:] Advances in Metals in Medicine, M. J. Abrams, B. A. Murrer (red.), J. A. Press, USA 1993, 115.
  • [52] P. J. Blower, J. Singh, S. E. M. Clarke, M. M. Bisundan, M. J. Went, J. Nucl. Med, 1990, 31.
  • [53] S. Top, M. Ehafa, A. Vessieres, J. Quiry, J. Vaissermann, D. W. Hughes, M. J. McGlinchly, J. P. Mormon, E. Thoreau, G. Jaquene, J. Am. Chem. Soc., 1995, 117, 8372.
  • [54] J. P. Dizio, R. Riashi, A. Davison, A. G. Jones, J. A Katzenellenbogen, Bioconj. Chem., 1991, 2, 353.
  • [55] F. Hosain, R. P. Spencer, H. M. Couthon, G. L. Sturtz, J. Nucl. Med., 1995, 36, 30.
  • [56] E. Deutsch, J. W. Brodack, K. F. Deutsch, Eur. J. Nucl. Med., 1993, 20, 1113.
  • [57] M. Chinol, S. Vallabhajoshula, S. J. Goldsmith, M. J. Klein, K. F. Deutsch, L. K. Chinen, J. W. Brodack, E. A. Deutsch, B. A. Watson, A. J. Tofe, J. Nucl. Med., 1993, 34, 1536.
  • [58] R. J. Rumper, U. Y. Ryo, M. Jay, ibid., 1991, 32, 2139.
  • [59] W. G Cole, S. J. DeNardo, C. F. Meares, M. J. McCall, G. L. DeNardo, A. L. Epstein, H. A. O. Brien, M. K. Moi, ibid., 1987, 28, 83.
  • [60] M. K. Moi, C. F. Meares, S. J. DeNardo, J. Am. Chem. Soc., 1988, 110, 6266.
  • [61] J. A. Mercer-Smith, S. D. Figard, D. K. Lavalle, J. Nucl. Med. 1985, 26, 437.
  • [62] G. L. Tolman, R. A. Hadjian, M. M. Morelock, ibid., 1985, 26, 438.
  • [63] H. Herzog, F. Rosch, G. Stocklin, C. Lueders, S. M. Qaim, E. L. Feinendegen, ibid., 1993, 34, 2222.
  • [64] A H. Soloway, W. Tjarks, B. A. Barnum, F.-G. Pong, R. F. Barth, I. M. Codogni, J. G. Wilson, Chem. Rev., 1988, 98, 1515.
  • [65] W. Tjarks, A. K. M. Anisuzzaman, L. Liu, A K. Soloway, R. F. Barth, D. J. Perkins, D. M. Adams, J. Med. Chem., 1992, 35, 1628.
  • [66] Z. J. Leśnikowski, R. F. Schinazi, J. Org. Chem., 1993, 58, 6531.
  • [67] H. Nemo to, J. Cai, Y. Yamamoto, J. Chem. Soc. Chem. Commun, 1994, 577.
  • [68] S. B. Kahl, R. A. Kasar, J. Am. Chem. Soc., 1996, 118, 1223.
  • [69] P. M. Jacobs, R. L. Sneath, A. H. Soloway, A. S. Dey, J. Pharm. Sei., 1976, 604, 65.
  • [70] A Sood, C. K. Sood, B. F. Spielvogel, Ł H. Hall, Eur. J. Med. Chem., 1990, 25, 301.
  • [71] M. Papaspyro, L. E. Feidegen, H. W. Muller-Gartner, Cancer Res., 1994, 54, 6311.
  • [72] H. Ghaneolhosseini, W. Tjarks, S. Sjoberg, Tetrahedron 1998, 54, 3877.
  • [73] F. Sweet, Steroids, 1981, 37, 223.
  • [74] P. J. Wood, M. Scobie, M. D. Threadgil, Int. J. Radiat Biol., 1996, 70, 587.
  • [75] I. W. Wyżlic, W. Tjarks, A. H. Soloway, D. J. Perkins, M. Burgos, K. P. O. Reilly, Inorg. Chem., 1996, 35, 4541.
  • [76] G W. Roscoe, J. W. Phillips, W. C. Gillchriest, J. Pharm. Sei., 1977, 66, 1505.
  • [77] M. Miura, P. L. Micca, C D. Fisher, J. C Heinrichs, J. A. Donaldson, G. C. Finkel, D. N. Slatkin, Int. J. Cancer, 1996, 68, 114.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-BUS1-0005-0030
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.